Presurgical psychosocial predictors of acute postsurgical pain and quality of life in children undergoing major surgery.
Jennifer A Rabbitts, Cornelius B Groenewald, Gabrielle G Tai...
https://pubmed.ncbi.nlm.nih.gov/25540939/Actively Recruiting
Led by Stanford University · Updated on 2026-03-18
45
Participants Needed
1
Research Sites
78 weeks
Total Duration
Researchers are evaluating whether melatonin can help teenagers undergoing major musculoskeletal surgery by improving their sleep. This feasibility clinical trial focuses on adolescents aged 12 to 18 who are scheduled for elective surgery for conditions such as scoliosis, kyphosis, spondylolisthesis, pectus surgery, or hip surgery. The study aims to assess how acceptable and practical melatonin use is for these youths and to identify the best ways to measure outcomes related to sleep, pain, and quality of life both shortly after surgery and months later. Participants will be randomly assigned to take either a 3mg fast-dissolve melatonin pill or a placebo pill daily before and after surgery. All participants will receive instructions on good sleep habits. They will wear an actigraphy device, which is like a watch, to monitor sleep patterns before and after surgery. The study includes a treatment phase starting 14 days before surgery and continuing 21 days after, as well as follow-up periods up to 3 months post-surgery. Teens and one of their caregivers will complete brief surveys twice daily for about five weeks and longer online surveys three times over four months. Researchers will monitor treatment adherence, side effects, study acceptability, and retention. They will also assess changes in sleep quality and duration, pain levels, and health-related quality of life. The total study duration involves activities from before surgery through a 3-month follow-up to gather comprehensive data on recovery and well-being.
CONDITIONS
Studying Melatonin and Recovery in Teens
J
Jennifer A Rabbitts, M.B.Ch.B.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Stanford University
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | 3mg Fast-Dissolve Melatonin Pill | 3mg Fast-Dissolve Placebo Pill |
|---|---|---|
| What it is | A fast-dissolve oral pill containing 3mg of melatonin, given daily before and after surgery. | A visually identical fast-dissolve oral pill that contains no melatonin (placebo), taken daily before and after surgery. |
| Role in trial | Investigational supplement tested for its effects on perioperative sleep, adherence, acceptability, and recovery. | Controls for expectation and study procedures; used as a comparison to isolate the effects of melatonin. |
| Primary use | To evaluate whether melatonin improves adherence, acceptability, perioperative sleep, and recovery after surgery. | To serve as a control and measure outcomes as they would occur without melatonin supplementation. |
| How it is given or performed | Taken orally as a fast-dissolve 3mg tablet once daily, starting 14 days before surgery, continuing through 21 days post-surgery, and at 3-month follow-up. | Taken orally as a fast-dissolve tablet once daily on the same schedule as the melatonin group. |
| Evidence status | Melatonin has been found to improve sleep onset in children and adolescents with insomnia, though its perioperative role in surgical patients remains investigational. | Placebo is not expected to provide specific benefit for sleep, adherence, or surgical recovery. |
| Important limitations | Most research on melatonin use is in children with chronic sleep onset insomnia or in adult perioperative settings, not specifically in youth after major musculoskeletal surgery. Potential for side effects or interactions requires monitoring. | Placebo does not provide an active treatment and does not account for standard pain or sleep management therapies that may be used outside the trial. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 14 days before surgery through 21 days after surgery
Participants take either melatonin or a placebo daily, wear an actigraphy device, and complete brief check-in surveys twice daily and longer online surveys during the treatment period around surgery.
Twice daily check-in surveys and 1 to 3 online surveys during this period
Duration - 7 days at 3-month follow-up
Participants complete additional surveys and treatment adherence assessments approximately 3 months after surgery to monitor recovery and outcomes.
Surveys and assessments during this week
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jennifer A Rabbitts, Cornelius B Groenewald, Gabrielle G Tai...
https://pubmed.ncbi.nlm.nih.gov/25540939/Sha Wei, Marcel G Smits, Xiangdong Tang...
https://pubmed.ncbi.nlm.nih.gov/31982807/Karen M Barlow, Brian L Brooks, Michael J Esser...
https://pubmed.ncbi.nlm.nih.gov/32217739/S Moore, L Stockbridge
https://pubmed.ncbi.nlm.nih.gov/5052847/Jennifer A Rabbitts, Chuan Zhou, Cornelius B Groenewald...
https://pubmed.ncbi.nlm.nih.gov/26381701/Jennifer A Rabbitts, Chuan Zhou, Arthi Narayanan...
https://pubmed.ncbi.nlm.nih.gov/28131699/M G Smits, E E Nagtegaal, J van der Heijden...
https://pubmed.ncbi.nlm.nih.gov/11292231/Bennedikte K Madsen, Dennis Zetner, Ann Merete Møller...
https://pubmed.ncbi.nlm.nih.gov/33319916/Wolnei Caumo, Fernanda Torres, Nívio L Moreira...
https://pubmed.ncbi.nlm.nih.gov/17959953/Farhanah Yousaf, Edwin Seet, Lashmi Venkatraghavan...
https://pubmed.ncbi.nlm.nih.gov/20823763/Stanford University
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsor